Nov 29, 2022

Featuring a slide presentation and related discussion from Dr Toni Choueiri, including the following topics:

• Evolution in the management of renal cell carcinoma (RCC) (0:00)
• Adjuvant therapy for intermediate- or high-risk RCC (1:52)
• Front-line therapy for patients with metastatic RCC (8:39)
• New agents for the treatment of relapsed or refractory RCC (16:24)
• Mechanism of action and efficacy of HIF2-alpha inhibitors for von Hippel-Lindau-associated RCC (19:56)

CME information and select publications